Shuo Yang, Yibing Hou, Xiaohui Wang, Shuo Kang, Zhenhua Pan. "Correction: Economic evaluation of atezolizumab in combination with bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer in China: A cost-effectiveness analysis." PLoS ONE (2026). https://doi.org/10.1371/journal.pone.0353864